Korea's ImmunoMet raises $5.2 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2016
Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of ...Read more
Cellworks, AstraZeneca join hands for TB research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012
Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies ...Read more
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015
Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repur...Read more
Genticel secures patent for a targeted therapy for cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015
Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cance...Read more
Hong Kong approves asthma drug flutiform
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formotero...Read more
FDA nod for Novartis eyecare firm's glaucoma drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2013
Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza s...Read more
FDA stamps Merck's Hep C drug as breakthough therapy
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2015
Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis...Read more
Astellas, FibroGen start CKD anemia trial in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...Read more
Aussie firm to begin human trial of cancer detecting antibody
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015
Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its nove...Read more
USFDA approves 'Female Viagra'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2015
US-based Sprout Pharmaceuticals gained USFDA's approval for Addyi, whose chemical name is Flibanserin, created to enhanc...Read more
BioDiem protozoan drug to get Japanese patent
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...Read more
Gilead submits NDA for cancer drug Idelalisib
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013
Singapore: Gilead Sciences has submitted a new drug application (NDA) to the US FDA for the approval of Idelalisib, an i...Read more
TWi's drug gets rare disease drug designation in Taiwan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2015
Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiw...Read more
Singapore scientists engineer human stem cells
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013
Singapore: A*Star's Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) c...Read more
Aussie firm likely to get orphan status for its new drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee ...Read more
Eisai, Nihon Medi-Physics to work on dementia intervention
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...Read more
French firm successfully completes Ph I trial of diabetes drug in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2015
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...Read more
Eisai launches In-house anticancer agent in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 May, 2015
Japan's leading pharmaceutical company Eisai Co. Ltd. has launched its in-house developed novel anticancer agent Lenvima...Read more